<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="Inc.Hoboken pmcid: 7537045 pmid: 32944968 doi: 10.15252/embj.2020106057EMBJ2020106057 : Article: Articles" exact="Cholesterol" post="25â€�Hydroxylase inhibits SARSâ€�CoVâ€�2 and other coronaviruses by depleting membrane"/>
 <result pre="RheumatologyDepartment of PediatricsUniversity of California San DiegoLa JollaCAUSA[5], Division of" exact="Infectious" post="Diseases and Global Public HealthDepartment of MedicineUniversity of California"/>
 <result pre="of PediatricsUniversity of California San DiegoLa JollaCAUSA[5], Division of Infectious" exact="Diseases" post="and Global Public HealthDepartment of MedicineUniversity of California San"/>
 <result pre="provided the original work is properly cited.file:EMBJ-9999-e106057.pdf Abstract Abstract Coronavirus" exact="disease" post="2019 (COVIDâ€�19) is caused by SARSâ€�CoVâ€�2 and has spread"/>
 <result pre="and has spread across the globe. SARSâ€�CoVâ€�2 is a highly" exact="infectious" post="virus with no vaccine or antiviral therapy available to"/>
 <result pre="pandemic; therefore, it is crucial to understand the mechanisms of" exact="viral" post="pathogenesis and the host immune responses to SARSâ€�CoVâ€�2. SARSâ€�CoVâ€�2"/>
 <result pre="like other closely related viruses including SARSâ€�CoV and Middle East" exact="respiratory" post="syndrome coronavirus (MERSâ€�CoV). Both SARSâ€�CoV and MERSâ€�CoV have caused"/>
 <result pre="other closely related viruses including SARSâ€�CoV and Middle East respiratory" exact="syndrome" post="coronavirus (MERSâ€�CoV). Both SARSâ€�CoV and MERSâ€�CoV have caused serious"/>
 <result pre="interferonâ€�stimulated genes (ISGs), cholesterol 25â€�hydroxylase (CH25H), is induced by SARSâ€�CoVâ€�2" exact="infection" post="inÂ vitro and in COVIDâ€�19â€�infected patients. CH25H converts cholesterol"/>
 <result pre="activity by blocking membrane fusion. Furthermore, 25HC inhibits USAâ€�WA1/2020 SARSâ€�CoVâ€�2" exact="infection" post="in lung epithelial cells and viral entry in human"/>
 <result pre="membrane fusion. Furthermore, 25HC inhibits USAâ€�WA1/2020 SARSâ€�CoVâ€�2 infection in lung" exact="epithelial" post="cells and viral entry in human lung organoids. Mechanistically,"/>
 <result pre="25HC inhibits USAâ€�WA1/2020 SARSâ€�CoVâ€�2 infection in lung epithelial cells and" exact="viral" post="entry in human lung organoids. Mechanistically, 25HC inhibits viral"/>
 <result pre="and viral entry in human lung organoids. Mechanistically, 25HC inhibits" exact="viral" post="membrane fusion by activating the ERâ€�localized acylâ€�CoA:cholesterol acyltransferase (ACAT)"/>
 <result pre="it provides a potential therapeutic candidate for COVIDâ€�19 and emerging" exact="viral" post="diseases in the future. Interferonâ€�induced cholesterol hydroxylation, and subsequent"/>
 <result pre="cholesterol 25â€�hydroxylase COVIDâ€�19 treatment innate immunity restriction factor of coronaviruses" exact="viral" post="fusion Subject Categories Membrane &amp;amp; Intracellular Transport Microbiology, Virology"/>
 <result pre="factor of coronaviruses viral fusion Subject Categories Membrane &amp;amp; Intracellular" exact="Transport" post="Microbiology, Virology &amp;amp; Host Pathogen Interaction Funding HHS|NIH|National Cancer"/>
 <result pre="Intracellular Transport Microbiology, Virology &amp;amp; Host Pathogen Interaction Funding HHS|NIH|National" exact="Cancer" post="Institute (NCI)CA177322 HHS|NIH|National Institute on Drug Abuse (NIDA) 10.13039/100000026"/>
 <result pre="Drug Abuse (NIDA) 10.13039/100000026 DA039562DA049524 HHS|NIH|National Institute of Allergy and" exact="Infectious" post="Diseases (NIAID)AI125103 fig-count: table-count: page-count: word-count: The EMBO Journal"/>
 <result pre="Abuse (NIDA) 10.13039/100000026 DA039562DA049524 HHS|NIH|National Institute of Allergy and Infectious" exact="Diseases" post="(NIAID)AI125103 fig-count: table-count: page-count: word-count: The EMBO Journal (2020)"/>
 <result pre="table-count: page-count: word-count: The EMBO Journal (2020) e10605732944968 Introduction Coronavirus" exact="disease" post="2019 (COVIDâ€�19) is a transmissible respiratory disease caused by"/>
 <result pre="(2020) e10605732944968 Introduction Coronavirus disease 2019 (COVIDâ€�19) is a transmissible" exact="respiratory" post="disease caused by a novel severe acute respiratory syndrome"/>
 <result pre="e10605732944968 Introduction Coronavirus disease 2019 (COVIDâ€�19) is a transmissible respiratory" exact="disease" post="caused by a novel severe acute respiratory syndrome coronavirus"/>
 <result pre="is a transmissible respiratory disease caused by a novel severe" exact="acute" post="respiratory syndrome coronavirus SARSâ€�CoVâ€�2. Since its emergence in December"/>
 <result pre="a transmissible respiratory disease caused by a novel severe acute" exact="respiratory" post="syndrome coronavirus SARSâ€�CoVâ€�2. Since its emergence in December 2019,"/>
 <result pre="transmissible respiratory disease caused by a novel severe acute respiratory" exact="syndrome" post="coronavirus SARSâ€�CoVâ€�2. Since its emergence in December 2019, COVIDâ€�19"/>
 <result pre="and other closely related viruses include SARSâ€�CoV and Middle East" exact="respiratory" post="syndrome coronavirus (MERSâ€�CoV). Both SARSâ€�CoV and MERSâ€�CoV caused serious"/>
 <result pre="other closely related viruses include SARSâ€�CoV and Middle East respiratory" exact="syndrome" post="coronavirus (MERSâ€�CoV). Both SARSâ€�CoV and MERSâ€�CoV caused serious outbreaks"/>
 <result pre="(Hoffmann etÂ al, 2020b). Interferons (IFNs) are induced upon coronavirus" exact="infections" post="(Park &amp;amp; Iwasaki, 2020). IFNs are signaling molecules of"/>
 <result pre="etÂ al, 2013). Upon sensing of molecular patterns associated with" exact="viral" post="infections, IFN pathways become activated, engendering further activation of"/>
 <result pre="in the virus life cycle (Liu etÂ al, 2013). Human" exact="type I" post="IFNs including IFNâ€�Î± and IFNâ€�Î² function through the ubiquitously"/>
 <result pre="IFNs including IFNâ€�Î± and IFNâ€�Î² function through the ubiquitously expressed" exact="type I" post="interferon receptor (IFNAR), while type III IFNs, IFNâ€�Î», bind"/>
 <result pre="through the ubiquitously expressed type I interferon receptor (IFNAR), while" exact="type III" post="IFNs, IFNâ€�Î», bind to the epitheliaâ€�restricted type III interferon"/>
 <result pre="(IFNAR), while type III IFNs, IFNâ€�Î», bind to the epitheliaâ€�restricted" exact="type III" post="interferon receptor (IFNLR; de Weerd &amp;amp; Nguyen, 2012). In"/>
 <result pre="and clinical studies have shown that SARSâ€�CoVâ€�2 is sensitive to" exact="type I" post="IFNs and that type I IFN treatment could be"/>
 <result pre="that SARSâ€�CoVâ€�2 is sensitive to type I IFNs and that" exact="type I" post="IFN treatment could be a promising therapeutic strategy for"/>
 <result pre="antiviral activity by inhibiting the host cell entry of human" exact="immunodeficiency" post="virus (HIV), vesicular stomatitis virus (VSV), Zika virus (ZIKV),"/>
 <result pre="the host cell entry of human immunodeficiency virus (HIV), vesicular" exact="stomatitis" post="virus (VSV), Zika virus (ZIKV), Ebola virus (EBOV), Nipah"/>
 <result pre="(VSV), Zika virus (ZIKV), Ebola virus (EBOV), Nipah virus (NiV)," exact="Russian" post="springâ€�summer encephalitis virus (RSSEV), porcine viruses (PEDV, PEGV, porcine"/>
 <result pre="virus (ZIKV), Ebola virus (EBOV), Nipah virus (NiV), Russian springâ€�summer" exact="encephalitis" post="virus (RSSEV), porcine viruses (PEDV, PEGV, porcine intestine coronavirus),"/>
 <result pre="treatment with 25HC protected mice and rhesus monkeys from ZIKV" exact="infection" post="(Li etÂ al, 2017). For the mechanism of entry"/>
 <result pre="antiviral activity of CH25H against SARSâ€�CoVâ€�2 entry into human lung" exact="epithelial" post="cells and show that 25HC broadly inhibits infection by"/>
 <result pre="human lung epithelial cells and show that 25HC broadly inhibits" exact="infection" post="by human coronaviruses including SARSâ€�CoV and MERSâ€�CoV. By addressing"/>
 <result pre="further confirmed the inhibitory effect of 25HC on authentic SARSâ€�CoVâ€�2" exact="infection" post="of lung epithelial cells and viral entry in human"/>
 <result pre="inhibitory effect of 25HC on authentic SARSâ€�CoVâ€�2 infection of lung" exact="epithelial" post="cells and viral entry in human lung organoids. These"/>
 <result pre="25HC on authentic SARSâ€�CoVâ€�2 infection of lung epithelial cells and" exact="viral" post="entry in human lung organoids. These results shed light"/>
 <result pre="on one of the mechanisms by which interferon signaling and" exact="type I" post="interferon therapy in COVIDâ€�19â€�infected patients counteract SARSâ€�CoVâ€�2 at the"/>
 <result pre="in broadâ€�spectrum antiviral immunity. Results CH25H is induced by SARSâ€�CoVâ€�2" exact="infection" post="and restricts viral entry Since CH25H is an ISG"/>
 <result pre="immunity. Results CH25H is induced by SARSâ€�CoVâ€�2 infection and restricts" exact="viral" post="entry Since CH25H is an ISG and broadly inhibits"/>
 <result pre="CH25H during SARSâ€�CoVâ€�2 infection. We analyzed RNAâ€�seq data of SARSâ€�CoVâ€�2" exact="infection" post="in two lung epithelial cell lines, Caluâ€�3 and A549â€�ACE2"/>
 <result pre="We analyzed RNAâ€�seq data of SARSâ€�CoVâ€�2 infection in two lung" exact="epithelial" post="cell lines, Caluâ€�3 and A549â€�ACE2 (Blancoâ€�Melo etÂ al, 2020),"/>
 <result pre="and A549â€�ACE2 (Blancoâ€�Melo etÂ al, 2020), for upâ€�regulated ISGs. SARSâ€�CoVâ€�2" exact="infection" post="dramatically induced type I and III interferons, including IFNB1"/>
 <result pre="etÂ al, 2020), for upâ€�regulated ISGs. SARSâ€�CoVâ€�2 infection dramatically induced" exact="type I" post="and III interferons, including IFNB1 and IFNL1, but not"/>
 <result pre="I and III interferons, including IFNB1 and IFNL1, but not" exact="type II" post="interferon (FigÂ 1A). Multiple wellâ€�known ISGs were simultaneously elevated,"/>
 <result pre="IFNB1 and IFNL1, but not type II interferon (FigÂ 1A)." exact="Multiple" post="wellâ€�known ISGs were simultaneously elevated, such as ISG15, OASL,"/>
 <result pre="both cell lines (FigÂ 1A). Similar results were obtained from" exact="infections" post="by human parainfluenza virus type 3 (HPIV3) and respiratory"/>
 <result pre="Similar results were obtained from infections by human parainfluenza virus" exact="type 3" post="(HPIV3) and respiratory syncytial virus (RSV) but not influenza"/>
 <result pre="from infections by human parainfluenza virus type 3 (HPIV3) and" exact="respiratory" post="syncytial virus (RSV) but not influenza A virus, whose"/>
 <result pre="COVIDâ€�19â€�infected patients revealed an upâ€�regulation of CH25H in macrophages and" exact="epithelial" post="cells in COVIDâ€�19â€�infected patients compared to healthy donors (FigsÂ"/>
 <result pre="donors (FigÂ EV1B; preprint: Daamen etÂ al, 2020). Figure 1" exact="Cholesterol" post="25â€�hydroxylase (CH25H) is induced by SARSâ€�CoVâ€�2 and restricts viral"/>
 <result pre="1 Cholesterol 25â€�hydroxylase (CH25H) is induced by SARSâ€�CoVâ€�2 and restricts" exact="viral infection" post="AIFNs and ISGs were induced by SARSâ€�CoV-2 infection in"/>
 <result pre="Cholesterol 25â€�hydroxylase (CH25H) is induced by SARSâ€�CoVâ€�2 and restricts viral" exact="infection" post="AIFNs and ISGs were induced by SARSâ€�CoV-2 infection in"/>
 <result pre="restricts viral infection AIFNs and ISGs were induced by SARSâ€�CoV-2" exact="infection" post="in lung epithelial cell lines: Caluâ€�3 and A549â€�ACE2 were"/>
 <result pre="AIFNs and ISGs were induced by SARSâ€�CoV-2 infection in lung" exact="epithelial" post="cell lines: Caluâ€�3 and A549â€�ACE2 were infected with SARSâ€�CoV-2"/>
 <result pre="(VSVâ€�G) were concentrated by ultracentrifuge. Incorporation of spike protein on" exact="viral" post="membrane was analyzed by Western blot using an antibody"/>
 <result pre="SARSâ€�CoV-2. VSV Matrix protein served as a loading control for" exact="viral" post="particles. Black arrows indicate full length S and cleaved"/>
 <result pre="S and cleaved spike (S2 subunit), respectively. (D) SARSâ€�CoV-2 pseudovirus" exact="infection" post="in Caluâ€�3 cells with or without treatment of coronavirus"/>
 <result pre="activity was measured to quantify the infection. (E) SARSâ€�CoV-2 pseudovirus" exact="infection" post="in Caluâ€�3 cells transduced with nonâ€�targeting control or ACE2â€�specific"/>
 <result pre="infected with SARSâ€�CoV-2 pseudovirus encoding Fluc or EGFP and pseudovirus" exact="infection" post="was quantified by luciferase assay (F) or visualized by"/>
 <result pre="we constructed SARSâ€�CoVâ€�2 pseudovirus based on VSV to investigate the" exact="viral" post="entry process. We first checked the expression SARSâ€�CoVâ€�2 spike"/>
 <result pre="mediated by the spike protein because EK1 treatment potently inhibited" exact="viral infection" post="in Caluâ€�3 cells (FigÂ 1D). To further authenticate our"/>
 <result pre="by the spike protein because EK1 treatment potently inhibited viral" exact="infection" post="in Caluâ€�3 cells (FigÂ 1D). To further authenticate our"/>
 <result pre="cells (FigÂ 1D). To further authenticate our pseudovirus, we tested" exact="infection" post="of the human lung epithelial cell line Caluâ€�3 treated"/>
 <result pre="authenticate our pseudovirus, we tested infection of the human lung" exact="epithelial" post="cell line Caluâ€�3 treated with TMPRSS2 inhibitors camostat and"/>
 <result pre="with TMPRSS2 inhibitors camostat and nafamostat (FigÂ EV1D). SARSâ€�CoVâ€�2 pseudovirus" exact="infection" post="was abolished in cells treated with inhibitors as compared"/>
 <result pre="with inhibitors as compared with vehicle control (FigÂ EV1D). Furthermore," exact="infection" post="was significantly repressed in ACE2 knockout Caluâ€�3 cells (FigsÂ"/>
 <result pre="results showed that overexpression of CH25H significantly suppressed SARSâ€�CoVâ€�2 pseudovirus" exact="infection" post="(FigÂ 1F and G). Taken together, these data suggest"/>
 <result pre="these data suggest that the upâ€�regulation of CH25H upon SARSâ€�CoVâ€�2" exact="infection" post="inÂ vitro and inÂ vivo restricts SARSâ€�CoVâ€�2 infection. 25â€�Hydroxycholesterol"/>
 <result pre="and inÂ vivo restricts SARSâ€�CoVâ€�2 infection. 25â€�Hydroxycholesterol (25HC) broadly inhibits" exact="viral" post="entry of human coronaviruses by blocking membrane fusion To"/>
 <result pre="by blocking membrane fusion To determine whether CH25H inhibits SARSâ€�CoVâ€�2" exact="infection" post="by 25HC production, Caluâ€�3 cells were treated with a"/>
 <result pre="were treated with a concentration gradient of 25HC, followed by" exact="infection" post="with SARSâ€�CoVâ€�2 pseudovirus encoding either Firefly luciferase or EGFP"/>
 <result pre="pseudovirus (FigÂ 2B). In light of the findings of SARSâ€�CoVâ€�2" exact="infection" post="in the gastrointestinal tract (Zang etÂ al, 2020), we"/>
 <result pre="gastrointestinal tract (Zang etÂ al, 2020), we asked whether the" exact="viral" post="inhibition by 25HC was specific to lung epithelial cells"/>
 <result pre="whether the viral inhibition by 25HC was specific to lung" exact="epithelial" post="cells or it was a broad cell type mechanism"/>
 <result pre="cells or it was a broad cell type mechanism for" exact="viral" post="entry. To address this question, we analyzed pseudovirus entry"/>
 <result pre="question, we analyzed pseudovirus entry into Cacoâ€�2 cells, a colorectal" exact="epithelial" post="cell line, which also expresses ACE2 and TMPRSS2 as"/>
 <result pre="and further 25HC does not exert significant background change in" exact="viral" post="gene expression (FigÂ EV2D). In contrast, 7Î±â€�HC, which is"/>
 <result pre="(FigÂ EV2E). Thus, our results show that 25HC limits SARSâ€�CoVâ€�2" exact="infection" post="in both lung and intestinal epithelial cells. Figure 2"/>
 <result pre="that 25HC limits SARSâ€�CoVâ€�2 infection in both lung and intestinal" exact="epithelial" post="cells. Figure 2 25â€�Hydrocholesterol (25HC) blocks entry of human"/>
 <result pre="After 2Â h of infection, virus was removed and pseudovirus" exact="infection" post="was quantified by luciferase assay at 24Â h postâ€�infection"/>
 <result pre="to challenge by SARSâ€�CoV-2 pseudovirus at 4Â°C for 1Â h." exact="Total" post="cellular RNA was extracted and quantified for VSVâ€�L by"/>
 <result pre="S (G, left), and MERSâ€�CoV S (G, right) in the" exact="absence of" post="EtOH or 25HC. At 24Â h postâ€�transfection, syncytium formation"/>
 <result pre="2.48Â Î¼M and 1.22Â Î¼M, respectively (FigÂ 2C and D," exact="upper" post="panels). This inhibition of infection was also confirmed by"/>
 <result pre="respectively (FigÂ 2C and D, upper panels). This inhibition of" exact="infection" post="was also confirmed by EGFPâ€�expressing pseudoviruses (FigÂ 2C and"/>
 <result pre="was also confirmed by EGFPâ€�expressing pseudoviruses (FigÂ 2C and D," exact="lower" post="panels). These data, altogether, suggest that 25HC is an"/>
 <result pre="of 25HC on virus fusion with target cells. To simulate" exact="viral" post="envelope fusion with plasma membrane, we performed cellâ€&quot;cell fusion"/>
 <result pre="reticulum (Du etÂ al, 2004). Intriguingly, a recent study on" exact="Listeria infection" post="of epithelial cells reveals that 25HC restricts Listeria monocytogenes"/>
 <result pre="(Du etÂ al, 2004). Intriguingly, a recent study on Listeria" exact="infection" post="of epithelial cells reveals that 25HC restricts Listeria monocytogenes"/>
 <result pre="al, 2004). Intriguingly, a recent study on Listeria infection of" exact="epithelial" post="cells reveals that 25HC restricts Listeria monocytogenes cellâ€�toâ€�cell dissemination"/>
 <result pre="on Listeria infection of epithelial cells reveals that 25HC restricts" exact="Listeria" post="monocytogenes cellâ€�toâ€�cell dissemination through mobilizing cholesterol molecules free of"/>
 <result pre="blocked human coronavirus fusion at the plasma membrane of lung" exact="epithelial" post="cells, we hypothesized that 25HC could inhibit SARSâ€�CoVâ€�2 entry"/>
 <result pre="on the plasma membrane (FigÂ 3A). Since we postulate a" exact="viral" post="entry mechanism at the plasma membrane and not via"/>
 <result pre="not via endosome, we first confirmed that SARSâ€�CoVâ€�2 enters lung" exact="epithelial" post="cells primarily through fusion at the plasma membrane and"/>
 <result pre="at the plasma membrane and not by endocytosis. We analyzed" exact="viral" post="entry in Caluâ€�3 and Vero cells in the presence"/>
 <result pre="We found that camostat mesylate, a TMPRSS2 inhibitor, dramatically reduced" exact="viral" post="entry in Caluâ€�3 cells and not in Vero cells"/>
 <result pre="EV3A and B). And cathepsin B/L inhibitor Eâ€�64d efficiently blocked" exact="viral" post="entry in Vero cells without effecting Caluâ€�3 infection (FigÂ"/>
 <result pre="efficiently blocked viral entry in Vero cells without effecting Caluâ€�3" exact="infection" post="(FigÂ EV3A and B). Therefore, the priming of spike"/>
 <result pre="(FigÂ EV3A and B). Therefore, the priming of spike triggering" exact="viral" post="fusion is mediated by TMPRSS2 on the plasma membrane"/>
 <result pre="endosome (Hoffmann etÂ al, 2020b). Figure 3 25â€�Hydrocholesterol (25HC) inhibits" exact="viral" post="entry through depleting accessible cholesterol on plasma membrane ARescue"/>
 <result pre="and supplement of additional cholesterol can reverse the depletion and" exact="viral" post="entry. B, C25HC depletes accessible cholesterol on the plasma"/>
 <result pre="PBS or 80Â Î¼M cholesterol for 1Â h prior to" exact="infection" post="with SARSâ€�CoV-2 pseudovirus. Entry of SARSâ€�CoV-2 pseudovirus (E and"/>
 <result pre="is dependent on TMPRSS2 but not endosomal cathepsin in lung" exact="epithelial" post="cells. Caluâ€�3 cells were treated with 10Â Î¼M camostat"/>
 <result pre="and reâ€�supplemented with EtOH or 25HC in the presence or" exact="absence of" post="80Â Î¼M cholesterol. 24Â h postâ€�transfection, syncytium formation was"/>
 <result pre="incubating cells with domain 4 of anthrolysin O (ALOD4), a" exact="bacterial" post="toxin that specifically traps accessible cholesterol at the plasma"/>
 <result pre="on the plasma membrane regulated by 25HC is essential for" exact="viral" post="fusion, the replenishment of cholesterol should rescue viral fusion"/>
 <result pre="essential for viral fusion, the replenishment of cholesterol should rescue" exact="viral" post="fusion and lead to virus entry. As expected, supplementing"/>
 <result pre="cholesterol to inhibit SARSâ€�CoVâ€�2 virusâ€&quot;cell fusion. Given that 25HC inhibits" exact="viral" post="entry of SARSâ€�CoV and MERSâ€�CoV (FigÂ 2C and D),"/>
 <result pre="Addition of cholesterol reversed the inhibitory function of 25HC on" exact="viral" post="entry for both SARSâ€�CoV and MERSâ€�CoV pseudoviruses (FigÂ 3G"/>
 <result pre="Since upon esterification by ACAT, cholesteryl esters are stored in" exact="cytosolic" post="lipid droplets, we used a lipid droplet stain to"/>
 <result pre="and analyzed lipid droplet formation. Our results showed that authentic" exact="virus infection" post="efficiently activated ACAT that was comparable to 25HC treatment"/>
 <result pre="analyzed lipid droplet formation. Our results showed that authentic virus" exact="infection" post="efficiently activated ACAT that was comparable to 25HC treatment"/>
 <result pre="define the specificity of ACAT inhibition and its effect on" exact="viral" post="entry, we silenced ACAT by shRNAs and analyzed pseudovirus"/>
 <result pre="by shRNAs and analyzed pseudovirus entry in the presence and" exact="absence of" post="25HC. We found that ACAT knockdown by shRNA enhanced"/>
 <result pre="Western blotting. D, EInhibition of ACAT activity by SZ58â€�035 rescues" exact="viral" post="entry viral entry. Caluâ€�3 cells were pretreated with ethanol"/>
 <result pre="D, EInhibition of ACAT activity by SZ58â€�035 rescues viral entry" exact="viral" post="entry. Caluâ€�3 cells were pretreated with ethanol or 5Â"/>
 <result pre="DMSO or 40Â Î¼M SZ58â€�305 for 1Â h prior to" exact="infection" post="with SARSâ€�CoV-2 pseudovirus. Luciferase activity was measured at 24â€�hour"/>
 <result pre="cells were challenged with SARSâ€�CoV-2 pseudovirus. 24Â h postâ€�pseudovirus challenge," exact="viral" post="entry was quantified by luciferase assays. Bar represents meanÂ"/>
 <result pre="membrane, thereby restricting SARSâ€�CoVâ€�2 entry. 25HC inhibits SARSâ€�CoVâ€�2 isolate USAâ€�WA1/2020" exact="infection" post="and viral entry in human lung organoids To further"/>
 <result pre="restricting SARSâ€�CoVâ€�2 entry. 25HC inhibits SARSâ€�CoVâ€�2 isolate USAâ€�WA1/2020 infection and" exact="viral" post="entry in human lung organoids To further confirm the"/>
 <result pre="treated with a concentration gradient of 25HC and SARSâ€�CoVâ€�2 USAâ€�WA1/2020" exact="infection" post="was quantified by evaluating viral RNA of the infected"/>
 <result pre="of 25HC and SARSâ€�CoVâ€�2 USAâ€�WA1/2020 infection was quantified by evaluating" exact="viral" post="RNA of the infected cells and their culture supernatants"/>
 <result pre="infected cells and their culture supernatants (FigÂ 5A and B)." exact="Viral" post="infection was inhibited by 25HC in a doseâ€�dependent manner."/>
 <result pre="cells and their culture supernatants (FigÂ 5A and B). Viral" exact="infection" post="was inhibited by 25HC in a doseâ€�dependent manner. The"/>
 <result pre="a doseâ€�dependent manner. The IC50 values, as determined by supernatant" exact="viral" post="RNA and intracellular viral RNA, are 382Â nM and"/>
 <result pre="IC50 values, as determined by supernatant viral RNA and intracellular" exact="viral" post="RNA, are 382Â nM and 363Â nM, respectively (FigÂ"/>
 <result pre="similar to the IC50 for the inhibition of SARSâ€�CoVâ€�2 pseudovirus" exact="infection" post="in Caluâ€�3 cells (FigÂ 2A). Supernatants of infected 25HCâ€�treated"/>
 <result pre="Because organoids are more physiologically relevant than cell lines as" exact="infection" post="models, we next sought to confirm the function of"/>
 <result pre="characterized by analyzing expression of ACE2, TMPRSS2, and alveolar cell" exact="epithelial" post="markers (SFTPC, SFTPB, HOPX; Tiwari etÂ al. Manuscript under"/>
 <result pre="pseudovirus. After 24Â h, luciferase activity was measured to quantify" exact="viral" post="levels. 25HC treatment significantly blocked SARSâ€�CoVâ€�2 entry in lung"/>
 <result pre="entry in lung organoids (FigÂ 5D). Altogether, results from lung" exact="epithelial" post="cells and organoids further support that 25HC efficiently blocks"/>
 <result pre="lung cells. Figure 5 25â€�Hydrocholesterol (25HC) inhibits SARSâ€�CoVâ€�2 isolate USAâ€�WA1/2020" exact="infection" post="and viral entry in human lung organoids A, B25HC"/>
 <result pre="Figure 5 25â€�Hydrocholesterol (25HC) inhibits SARSâ€�CoVâ€�2 isolate USAâ€�WA1/2020 infection and" exact="viral" post="entry in human lung organoids A, B25HC inhibits SARSâ€�CoV-2"/>
 <result pre="in human lung organoids A, B25HC inhibits SARSâ€�CoV-2 USAâ€�WA1/2020 strain" exact="infection" post="in Caluâ€�3 cells. Cells were pretreated with ethanol or"/>
 <result pre="mechanism of CH25H, an interferonâ€�inducible gene robustly upâ€�regulated in lung" exact="epithelial" post="cell lines infected with SARSâ€�CoVâ€�2 and in COVIDâ€�19â€�infected patients."/>
 <result pre="broadâ€�spectrum antiviral activity against human coronaviruses. Further mechanistic studies revealed" exact="viral" post="membrane fusion was blocked by this oxysterol. Previous studies"/>
 <result pre="etÂ al, 2017). However, the mechanism by which 25HC modulates" exact="viral" post="entry is still unknown. In addressing the mechanism of"/>
 <result pre="of this oxysterol. Sterols and oxysterols influence immune system and" exact="viral" post="infections through both general and cellâ€�specific mechanisms (Spann &amp;amp;"/>
 <result pre="this oxysterol. Sterols and oxysterols influence immune system and viral" exact="infections" post="through both general and cellâ€�specific mechanisms (Spann &amp;amp; Glass,"/>
 <result pre="through both general and cellâ€�specific mechanisms (Spann &amp;amp; Glass, 2013)." exact="Cholesterol" post="has multiple functions on lipid bilayers. An increase or"/>
 <result pre="cholesterol could affect the function of integral membrane proteins, including" exact="viral" post="receptor or coâ€�receptors, by altering their conformation or distribution"/>
 <result pre="or indirectly affect virusâ€&quot;cell membrane fusion, which is essential for" exact="viral" post="genome release (Chazal &amp;amp; Gerlier, 2003). The depletion of"/>
 <result pre="2003). The depletion of cholesterol by 25HC did not affect" exact="viral" post="binding and TMPRSS2 priming (FigsÂ 2E and EV3F). It"/>
 <result pre="decreases accessible cholesterol at the plasma membrane without altering the" exact="total" post="cellular cholesterol; therefore, it may cause lower cytotoxicity or"/>
 <result pre="without altering the total cellular cholesterol; therefore, it may cause" exact="lower" post="cytotoxicity or side effects than statin use. For example,"/>
 <result pre="were collected and filtered through 0.22Â Î¼m filters to remove" exact="residual" post="vaccinia virus. 293FT cells transfected with pMD2.G (addgene 12259)"/>
 <result pre="collected and filtered through 0.22Â Î¼m filters to remove residual" exact="vaccinia" post="virus. 293FT cells transfected with pMD2.G (addgene 12259) encoding"/>
 <result pre="cells were counted and used to calculate virus titer as" exact="infectious" post="unit per milliliter (IU/ml). Titration of FLucâ€�expressing pseudoviruses was"/>
 <result pre="antibody and VSV matrix antibody. SARSâ€�CoVâ€�2, SARSâ€�CoV, and MERSâ€�CoV pseudovirus" exact="infection" post="and inhibitors treatment Cells were pretreated with 25HC for"/>
 <result pre="of SARSâ€�CoVâ€�2â€�S, SARSâ€�CoVâ€�S, and MERSâ€�CoVâ€�S using Lipofectamine 3000, in the" exact="absence of" post="EtOH or 25HC. 4Â h postâ€�transfection, fresh medium containing"/>
 <result pre="present during the treatment with 25HC and incubation with ALOD4." exact="Cholesterol" post="and Sandoz 58â€�035 rescue assays Caluâ€�3 cells were pretreated"/>
 <result pre="DMSO or 40Â Î¼M SZ58â€�035 for 1Â h prior to" exact="infection" post="with SARSâ€�CoVâ€�2 pseudovirus. For pseudovirus with Fluc, the cells"/>
 <result pre="5Â Î¼M 25HC overnight. Caluâ€�3 cells were washed prior to" exact="infection" post="with SARSâ€�CoVâ€�2 pseudovirus. The cells were lysed and subjected"/>
 <result pre="luciferase activity measurement at 24Â h postâ€�infection. SARSâ€�CoVâ€�2 isolate USAâ€�WA1/2020" exact="infection" post="SARSâ€�CoVâ€�2 isolate USAâ€�WA1/2020 was obtained from BEI Resources. SARSâ€�CoVâ€�2"/>
 <result pre="USAâ€�WA1/2020 was obtained from BEI Resources. SARSâ€�CoVâ€�2 was propagated and" exact="infectious" post="units quantified by plaque assay using Vero E6 cells."/>
 <result pre="The primers are as follows: SARSâ€�CoV-2â€�N (Forward: CACATTGGCACCCGCAATC; Reverse: GAGGAACGAGAAGAGGCTTG)." exact="Viral" post="titer in supernatant was quantified by plaque assay in"/>
 <result pre="min. The signals were captured by fluorescence microscope. For the" exact="infection" post="with live SARSâ€�CoVâ€�2 virus, Caluâ€�3 cells were infected with"/>
 <result pre="was captured by Incucyte S3. Lung Organoid 25HC treatment and" exact="infection" post="Human iPSC derived lung organoids were generated using previously"/>
 <result pre="and characterized by expression of ACE2, TMPRSS2 and alveolar cell" exact="epithelial" post="markers (SFTPC, SFTPB, HOPX) (Tiwari etÂ al, Manuscript under"/>
 <result pre="25HC. After 24Â h, luciferase activity was measured to quantify" exact="viral infection." post="Lentivirus production and transduction Two sgRNA oligos targeting ACE2"/>
 <result pre="v2 (addgene 52961) and two shRNA oligos targeting ACAT1 and" exact="ACAT2" post="were cloned into pLKO.1 (addgene 8453). CH25H was cloned"/>
 <result pre="For the RNAâ€�seq data from SARSâ€�CoVâ€�2, IAV, HPIV3, and RSV" exact="infection" post="(Blancoâ€�Melo etÂ al, 2020), target gene expression in infected"/>
 <result pre="(SD). Data availability This study includes no data deposited in" exact="external" post="repositories. Author contributions SW designed and performed experiments, analyzed"/>
 <result pre="advice. The following reagent was deposited by the Centers for" exact="Disease" post="Control and Prevention and obtained through BEI Resources, NIAID,"/>
 <result pre="McDonaldJG, SchogginsJW, RadhakrishnanAetÂ al (2020) Oxysterols provide innate immunity to" exact="bacterial infection" post="by mobilizing cell surface accessible cholesterol. Nat Microbiol5: 929â€&quot;94232284563"/>
 <result pre="SchogginsJW, RadhakrishnanAetÂ al (2020) Oxysterols provide innate immunity to bacterial" exact="infection" post="by mobilizing cell surface accessible cholesterol. Nat Microbiol5: 929â€&quot;94232284563"/>
 <result pre="EmdinM, TaddeiS, VergaroG (2020) Statin therapy in COVIDâ€�19 infection. Eur" exact="Heart" post="J Cardiovasc Pharmacother6: 258â€&quot;25932347925 ChazalN, GerlierD (2003) Virus entry,"/>
 <result pre="MizutaniT, SaijoM, MatsuyamaS, MiyajimaN, TaguchiF, ItamuraS, KuraneI, MorikawaS (2005) Vesicular" exact="stomatitis" post="virus pseudotyped with severe acute respiratory syndrome coronavirus spike"/>
 <result pre="ItamuraS, KuraneI, MorikawaS (2005) Vesicular stomatitis virus pseudotyped with severe" exact="acute" post="respiratory syndrome coronavirus spike protein. J Gen Virol86: 2269â€&quot;227416033974"/>
 <result pre="KuraneI, MorikawaS (2005) Vesicular stomatitis virus pseudotyped with severe acute" exact="respiratory" post="syndrome coronavirus spike protein. J Gen Virol86: 2269â€&quot;227416033974 GayA,"/>
 <result pre="MorikawaS (2005) Vesicular stomatitis virus pseudotyped with severe acute respiratory" exact="syndrome" post="coronavirus spike protein. J Gen Virol86: 2269â€&quot;227416033974 GayA, RyeD,"/>
 <result pre="site in the spike protein of SARSâ€�CoVâ€�2 is essential for" exact="infection" post="of human lung cells. Mol Cell78: 779â€&quot;784.e532362314 HoffmannM, Kleineâ€�WeberH,"/>
 <result pre="ShojaieS, NathanN, SnyderE, PostM (2019) Reversal of surfactant protein B" exact="deficiency" post="in patient specific human induced pluripotent stem cell derived"/>
 <result pre="WatanabeM, DongHL, LiuPetÂ al (2017) 25â€�hydroxycholesterol protects host against zika" exact="virus infection" post="and its associated microcephaly in a mouse model. Immunity46:"/>
 <result pre="DongHL, LiuPetÂ al (2017) 25â€�hydroxycholesterol protects host against zika virus" exact="infection" post="and its associated microcephaly in a mouse model. Immunity46:"/>
 <result pre="25â€�hydroxycholesterol protects host against zika virus infection and its associated" exact="microcephaly" post="in a mouse model. Immunity46: 446â€&quot;45628314593 LiaoM, LiuY, YuanJ,"/>
 <result pre="PernetO, GuoH, NusbaumR, ZackJAetÂ al (2013) Interferonâ€�inducible cholesterolâ€�25â€�hydroxylase broadly inhibits" exact="viral" post="entry by production of 25â€�hydroxycholesterol. Immunity38: 92â€&quot;10523273844 LundEG, KerrTA,"/>
 <result pre="34316â€&quot;343279852097 MantloE, BukreyevaN, MaruyamaJ, PaesslerS, HuangC (2020) Antiviral activities of" exact="type I" post="interferons to SARSâ€�CoVâ€�2 infection. Antiviral Res179: 10481132360182 MpengZ, WangT,"/>
 <result pre="of recombinant human interferon alpha nasal drops to prevent coronavirus" exact="disease" post="2019 in medical staff in an epidemic area. medRxiv10.1101/2020.04.11.20061473"/>
 <result pre="flavivirus infection. Front Cell Infect Microbiol8: 38830450339 ParkA, IwasakiA (2020)" exact="Type I" post="and Type III interferons â€&quot; induction, signaling, evasion, and"/>
 <result pre="Cell Infect Microbiol8: 38830450339 ParkA, IwasakiA (2020) Type I and" exact="Type III" post="interferons â€&quot; induction, signaling, evasion, and application to combat"/>
 <result pre="fibrosis and angiotensinâ€�converting enzymeâ€�2 expression in glucoseâ€�controlled diabetic rat hearts." exact="Heart" post="Vessels32: 618â€&quot;62728013371 SpannNJ, GlassCK (2013) Sterols and oxysterols in"/>
 <result pre="Tissue specific up regulation of ACE2 in rabbit model of" exact="atherosclerosis" post="by atorvastatin: role of epigenetic histone modifications. Biochem Pharmacol93:"/>
 <result pre="BruloisKF, WangX, GreenbergHBetÂ al (2020) TMPRSS2 and TMPRSS4 promote SARSâ€�CoVâ€�2" exact="infection" post="of human small intestinal enterocytes. Sci Immunol5: eabc358232404436 ZhangXJ,"/>
</results>
